JP2008535907A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008535907A5 JP2008535907A5 JP2008505998A JP2008505998A JP2008535907A5 JP 2008535907 A5 JP2008535907 A5 JP 2008535907A5 JP 2008505998 A JP2008505998 A JP 2008505998A JP 2008505998 A JP2008505998 A JP 2008505998A JP 2008535907 A5 JP2008535907 A5 JP 2008535907A5
- Authority
- JP
- Japan
- Prior art keywords
- average
- active agent
- formulation
- max
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000013543 active substance Substances 0.000 claims 58
- 238000009472 formulation Methods 0.000 claims 55
- 239000000203 mixture Substances 0.000 claims 55
- 208000005145 Cerebral amyloid angiopathy Diseases 0.000 claims 35
- 230000036470 plasma concentration Effects 0.000 claims 27
- 208000024827 Alzheimer disease Diseases 0.000 claims 21
- 150000003839 salts Chemical class 0.000 claims 17
- LZXHHNKULPHARO-UHFFFAOYSA-M (3,4-dichlorophenyl)methyl-triphenylphosphanium;chloride Chemical compound [Cl-].C1=C(Cl)C(Cl)=CC=C1C[P+](C=1C=CC=CC=1)(C=1C=CC=CC=1)C1=CC=CC=C1 LZXHHNKULPHARO-UHFFFAOYSA-M 0.000 claims 16
- SNKZJIOFVMKAOJ-UHFFFAOYSA-N 3-Amino-1-propanesulfonic acid Natural products NCCCS(O)(=O)=O SNKZJIOFVMKAOJ-UHFFFAOYSA-N 0.000 claims 16
- 239000003937 drug carrier Substances 0.000 claims 9
- 230000003920 cognitive function Effects 0.000 claims 4
- 239000012729 immediate-release (IR) formulation Substances 0.000 claims 3
- 230000006999 cognitive decline Effects 0.000 claims 2
- 208000010877 cognitive disease Diseases 0.000 claims 2
- 239000002552 dosage form Substances 0.000 claims 2
- 230000000694 effects Effects 0.000 claims 2
- KCXFHTAICRTXLI-UHFFFAOYSA-N propane-1-sulfonic acid Chemical group CCCS(O)(=O)=O KCXFHTAICRTXLI-UHFFFAOYSA-N 0.000 claims 2
- 230000000087 stabilizing effect Effects 0.000 claims 2
- 206010003694 Atrophy Diseases 0.000 claims 1
- 206010012289 Dementia Diseases 0.000 claims 1
- 230000037444 atrophy Effects 0.000 claims 1
- 239000000090 biomarker Substances 0.000 claims 1
- 239000008280 blood Substances 0.000 claims 1
- 210000004369 blood Anatomy 0.000 claims 1
- 210000004556 brain Anatomy 0.000 claims 1
- 238000013270 controlled release Methods 0.000 claims 1
- 230000001054 cortical effect Effects 0.000 claims 1
- 230000003111 delayed effect Effects 0.000 claims 1
- 238000011156 evaluation Methods 0.000 claims 1
- 238000013265 extended release Methods 0.000 claims 1
- 230000002496 gastric effect Effects 0.000 claims 1
- 230000000971 hippocampal effect Effects 0.000 claims 1
- 230000003204 osmotic effect Effects 0.000 claims 1
- 230000001991 pathophysiological effect Effects 0.000 claims 1
- 230000000541 pulsatile effect Effects 0.000 claims 1
- 238000013268 sustained release Methods 0.000 claims 1
- 239000012730 sustained-release form Substances 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US67022405P | 2005-04-12 | 2005-04-12 | |
| PCT/IB2006/003865 WO2007069073A2 (en) | 2005-04-12 | 2006-04-12 | Pharmaceutical formulations of amyloid inhibiting compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008535907A JP2008535907A (ja) | 2008-09-04 |
| JP2008535907A5 true JP2008535907A5 (enExample) | 2009-05-21 |
Family
ID=38163292
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008505998A Pending JP2008535907A (ja) | 2005-04-12 | 2006-04-12 | アミロイド阻害化合物の薬学的製剤 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20060251714A1 (enExample) |
| EP (1) | EP1890685A2 (enExample) |
| JP (1) | JP2008535907A (enExample) |
| KR (1) | KR20070120190A (enExample) |
| CN (1) | CN101193628A (enExample) |
| CA (1) | CA2611586A1 (enExample) |
| WO (1) | WO2007069073A2 (enExample) |
| ZA (1) | ZA200708699B (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007023389A2 (en) * | 2005-07-21 | 2007-03-01 | Neurochem (International) Limited | Polymorphic forms of 3-amino-1-propanesulfonic acid |
| DK2089417T3 (en) | 2006-10-12 | 2015-03-23 | Bhi Ltd Partnership | Methods, Compounds, Compositions and Vehicles for Delivery of 3-Amion-1-Propanesulfonic Acid |
| WO2010096925A1 (en) * | 2009-02-26 | 2010-09-02 | Bellus Health (International) Limited | Homotaurine-supplemented and/or enriched edible material, methods of preparation an d uses |
| CN103875786A (zh) * | 2014-02-27 | 2014-06-25 | 如皋市坝新肠衣有限公司 | 一种肠衣的生产工艺 |
| EP4275750B1 (en) * | 2015-09-10 | 2026-05-06 | Alzheon, Inc. | Treatment of alzheimer's disease in a particular patient population |
| AU2021218735A1 (en) * | 2020-02-13 | 2022-09-01 | Cognition Therapeutics, Inc. | Method of decreasing amyloid beta monomer levels in patients with cognitive decline |
| US12336972B2 (en) * | 2021-01-22 | 2025-06-24 | Celagenex Research (India) Pvt. Ltd. | Synergistic nutritional compositions for treating neurocognitive disorders |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5840294A (en) * | 1993-03-29 | 1998-11-24 | Queen's University At Kingston | Method for treating amyloidosis |
| US5972328A (en) * | 1993-03-29 | 1999-10-26 | Queen's University At Kingston | Method for treating amyloidosis |
| US5643562A (en) * | 1993-03-29 | 1997-07-01 | Queen's University Of Kingston | Method for treating amyloidosis |
| JPH07223970A (ja) * | 1994-02-10 | 1995-08-22 | Tanabe Seiyaku Co Ltd | 消化管内適所放出製剤 |
| ES2188657T3 (es) * | 1994-04-22 | 2003-07-01 | Yamanouchi Pharma Co Ltd | Sistema para la liberacion especifica en el colon de un farmaco. |
| EP0957749A2 (en) * | 1995-09-12 | 1999-11-24 | The General Hospital Corporation | Method for early detection of ovarian cancer |
| US20020022657A1 (en) * | 1998-02-11 | 2002-02-21 | Francine Gervais | Methods for modulating neuronal cell death |
| US6310073B1 (en) * | 1998-07-28 | 2001-10-30 | Queen's University At Kingston | Methods and compositions to treat glycosaminoglycan-associated molecular interactions |
| EP1251837A2 (en) * | 1999-12-23 | 2002-10-30 | Neurochem, Inc. | Compounds and methods for modulating cerebral amyloid angiopathy |
| FR2832928B1 (fr) * | 2001-11-30 | 2004-02-06 | Dermo Cosmologie Lab De | Composition a base d'ester de diosgenine applicable par voie topique |
| US20050031651A1 (en) * | 2002-12-24 | 2005-02-10 | Francine Gervais | Therapeutic formulations for the treatment of beta-amyloid related diseases |
| US20060079578A1 (en) * | 2003-06-23 | 2006-04-13 | Julie Laurin | Pharmaceutical formulations of amyloid inhibiting compounds |
| US20050038000A1 (en) * | 2003-06-23 | 2005-02-17 | Xianqi Kong | Methods and compositions for the treatment of amyloid-and epileptogenesis-associated diseases |
| US20050142191A1 (en) * | 2003-06-23 | 2005-06-30 | Neurochem (International) Limited | Pharmaceutical formulations of amyloid inhibiting compounds |
| US20050215562A1 (en) * | 2003-06-23 | 2005-09-29 | Patrick Tremblay | Methods for treating protein aggregation disorders |
| US7414076B2 (en) * | 2003-06-23 | 2008-08-19 | Neurochem (International) Limited | Methods and compositions for treating amyloid-related diseases |
| US7244764B2 (en) * | 2003-06-23 | 2007-07-17 | Neurochem (International) Limited | Methods and compositions for treating amyloid-related diseases |
| US7253306B2 (en) * | 2003-06-23 | 2007-08-07 | Neurochem (International) Limited | Pharmaceutical drug candidates and methods for preparation thereof |
-
2006
- 2006-04-12 CA CA002611586A patent/CA2611586A1/en not_active Abandoned
- 2006-04-12 WO PCT/IB2006/003865 patent/WO2007069073A2/en not_active Ceased
- 2006-04-12 CN CNA2006800206830A patent/CN101193628A/zh active Pending
- 2006-04-12 US US11/402,267 patent/US20060251714A1/en not_active Abandoned
- 2006-04-12 EP EP06831844A patent/EP1890685A2/en not_active Withdrawn
- 2006-04-12 JP JP2008505998A patent/JP2008535907A/ja active Pending
- 2006-04-12 US US11/402,277 patent/US20060257480A1/en not_active Abandoned
- 2006-04-12 KR KR1020077026152A patent/KR20070120190A/ko not_active Withdrawn
-
2007
- 2007-10-11 ZA ZA200708699A patent/ZA200708699B/xx unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102795284B1 (ko) | 베타-히드록시부티레이트 및 부탄디올의 s-거울상이성질체 및 이의 사용 방법 | |
| JP7502197B2 (ja) | セピアプテリン血漿曝露を増加させるための方法 | |
| CN100577171C (zh) | 治疗重度心力衰竭的药物 | |
| JP2009513713A5 (enExample) | ||
| WO2018193648A1 (ja) | アルカリ性化剤による血液浄化 | |
| JP2024544572A (ja) | Ｒｏｃｋ２阻害剤のナノ結晶製剤およびその調製方法 | |
| JP2022507533A (ja) | 肺動脈性高血圧症および他疾患に関連する肺動脈性肺高血圧症の治療法 | |
| CN120091814A (zh) | 用slc6a19功能的哌啶抑制剂治疗pku的给药方案 | |
| CN102149377A (zh) | 决奈达隆在制备用于预防中风或短暂性缺血发作的药物中的用途 | |
| JP5680412B2 (ja) | レオヌリンの使用およびその組成物 | |
| JP2008535907A5 (enExample) | ||
| JP2009526834A5 (enExample) | ||
| JPH08503710A (ja) | ヒドロキシカルバゾール化合物の抗酸化心臓保護的使用およびそれを使用する治療方法 | |
| US20050043274A1 (en) | Pharmaceutical compositions and methods for lowering blood pressure and pulse rate | |
| HU229214B1 (hu) | Propionil-L-karnitint és további hatóanyagokat tartalmazó kombinációs készítmény alkalmazása merevedési zavar kezelésére | |
| RU2391095C1 (ru) | Фармацевтическая композиция, включающая холина альфосцерат и гопантеновую кислоту (или ее соль), для лечения недостаточности кровообращения мозга и эректильной дисфункции | |
| WO1996004917A1 (en) | Remedy for myotonic dystrophy | |
| JP2020514347A (ja) | チオトロピウムを有効成分として含有する近視予防、近視治療および／または近視進行抑制剤 | |
| JP5576006B2 (ja) | １日２回服用型経口投与製剤 | |
| JP5376785B2 (ja) | 医薬組成物 | |
| JP2010013364A (ja) | 高尿酸血症の予防または改善剤 | |
| JP6188784B2 (ja) | 炎症性および免疫性疾患の治療のための組成物 | |
| JP2019001830A (ja) | 医薬 | |
| JP5962161B2 (ja) | 耳管開放症治療剤 | |
| JP5366386B2 (ja) | 神経細胞賦活及び神経伸長促進用組成物 |